OneAscent Financial Services’s Ascendis Pharma A/S ASND Stock Holding History

OneAscent Financial Services’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,391	Closed	-$315K	–	201
2022 Q2	$315K	Sell	3,391 -787	-19%	-$74.2K	0.14%	134
2022 Q1	$490K	Buy	4,178 +618	+17%	+$71.6K	0.35%	39
2021 Q4	$479K	Buy	3,560 +109	+3%	+$16.2K	0.91%	31
2021 Q3	$550K	Buy	+3,451	New	+$472K	0.73%	17
2021 Q1	$470K	Buy	3,646 +929	+34%	+$141K	0.46%	46
2020 Q4	$453K	Sell	2,717 -2,769	-50%	-$458K	0.48%	42
2020 Q3	$847K	Buy	5,486 +1,210	+28%	+$174K	0.44%	32
2020 Q2	$632K	Buy	4,276 +818	+24%	+$112K	0.42%	37
2020 Q1	$389K	Sell	3,458 -1,899	-35%	-$247K	0.29%	55
2019 Q4	$745K	Buy	+5,357	New	+$595K	0.41%	26
2019 Q3	–	Sell	-3,891	Closed	-$448K	–	30
2019 Q2	$448K	Buy	+3,891	New	+$466K	0.31%	59

Other funds holding ASND

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

OneAscent Financial Services's ASND Position: Q3 2022 in Review

OneAscent Financial Services sold out of Ascendis Pharma A/S (ASND) in Q3 2022, closing a stake of 3,391 shares — an estimated $315K sold.

OneAscent Financial Services first reported a position in ASND in Q2 2019 and held it in 11 quarters. The position peaked at $847K in Q3 2020. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

OneAscent Financial Services reported no remaining Ascendis Pharma A/S position as of Q3 2022 after selling out during the quarter.
OneAscent Financial Services sold 3,391 Ascendis Pharma A/S shares in Q3 2022, an estimated $315K.
OneAscent Financial Services first reported a position in Ascendis Pharma A/S in Q2 2019 and held it in 11 quarters.
OneAscent Financial Services's Ascendis Pharma A/S position peaked at $847K in Q3 2020.
183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on OneAscent Financial Services's 13F filing for Q3 2022, filed 2 Nov 2022.